Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
flyntrade's Profile
Displaying 1-50 of 279 result(s).
CYDY CytoDyn Inc
11/18/2020 2:05:21 PM
Where to start on your errors. Firs (1)
CYDY CytoDyn Inc
11/18/2020 12:22:45 PM
You are mistaken. The facts are HGE (1)
CYDY CytoDyn Inc
10/30/2020 6:43:07 AM
Nice quote. No source.
CYDY CytoDyn Inc
10/26/2020 9:29:05 PM
It is hard enough dealing with the (2)
CYDY CytoDyn Inc
10/26/2020 9:20:51 PM
You are correct. My bad. I thought (5)
CYDY CytoDyn Inc
10/26/2020 8:45:51 PM
1+1=2 Get a clue. It is a SEC form (5)
CYDY CytoDyn Inc
10/26/2020 8:21:10 PM
These are shares they got as part o (1)
CYDY CytoDyn Inc
10/26/2020 3:04:06 PM
Great news Covid hospitalizations a (1)
CYDY CytoDyn Inc
10/24/2020 5:14:03 PM
"Looks like Mexico might dance to i (4)
CYDY CytoDyn Inc
10/24/2020 4:44:26 PM
We can only hope he takes it as the (2)
CYDY CytoDyn Inc
10/24/2020 3:58:32 PM
Posted on YMB by Nick AN OPEN LETTE (22)
CYDY CytoDyn Inc
10/12/2020 8:47:15 PM
I guess this means we will know the (2)
CYDY CytoDyn Inc
10/11/2020 1:36:39 PM
Where can I enroll in your trial?
CYDY CytoDyn Inc
10/11/2020 1:34:26 PM
60 minutes tonight will focus on Re (2)
CYDY CytoDyn Inc
10/07/2020 4:28:26 PM
I would have preferred he used the
CYDY CytoDyn Inc
10/07/2020 3:51:36 PM
He could have mentioned our current (1)
CYDY CytoDyn Inc
10/07/2020 2:33:58 PM
Here is the email I sent to Dr Kell (11)
CYDY CytoDyn Inc
10/07/2020 2:20:33 PM
Finally took my advise! (1)
CYDY CytoDyn Inc
10/05/2020 12:55:52 PM
Dr Kelly would be able to talk abou (1)
CYDY CytoDyn Inc
10/05/2020 12:07:15 PM
CEO of HGEN gave this short intervi (1)
CYDY CytoDyn Inc
10/04/2020 9:44:53 AM
This article is a month old but wor (1)
CYDY CytoDyn Inc
10/03/2020 9:00:11 PM
Dr. Jay has 167 followers after he
CYDY CytoDyn Inc
10/03/2020 1:43:21 PM
I am not saying to spend a dime on (2)
CYDY CytoDyn Inc
10/03/2020 12:49:01 PM
By getting LL out in the mass media
CYDY CytoDyn Inc
10/03/2020 12:44:19 PM
We have a window of opportunity wit (2)
CYDY CytoDyn Inc
10/03/2020 10:31:45 AM
"No trial results for leronlimab ye (3)
CYDY CytoDyn Inc
10/03/2020 10:04:55 AM
Many on this board voted NO on the (8)
CYDY CytoDyn Inc
10/03/2020 8:38:05 AM
What ever happened to Melissa Dodd. (2)
CYDY CytoDyn Inc
10/02/2020 4:47:53 PM
Why on earth would they buy ad time
CYDY CytoDyn Inc
10/02/2020 4:45:42 PM
OK we are in play, but Regeneron is
CYDY CytoDyn Inc
10/02/2020 4:37:59 PM
At least we are hearing about treat
CYDY CytoDyn Inc
10/02/2020 4:26:38 PM
Fox reported that as well. Wish we (2)
CYDY CytoDyn Inc
10/02/2020 3:01:19 PM
That is Nader speak so he must be t (11)
CYDY CytoDyn Inc
09/30/2020 5:38:41 PM
That is for sure!
CYDY CytoDyn Inc
09/27/2020 10:01:44 AM
The DSMB met on Thursday July 30 on
CYDY CytoDyn Inc
09/26/2020 11:55:01 AM
Keeping an eye on the competition.
CYDY CytoDyn Inc
09/25/2020 2:18:41 PM
That is what "penny" stocks do. The (1)
CYDY CytoDyn Inc
09/22/2020 10:08:26 PM
Check at 40:40 about Uplisting. HOP
CYDY CytoDyn Inc
09/18/2020 6:53:33 PM
I am also un clear just how this in (3)
CYDY CytoDyn Inc
09/18/2020 5:45:53 PM
"Most of the people calling for a c (5)
CYDY CytoDyn Inc
09/18/2020 10:29:07 AM
OK we agree then that NP is a hard (4)
CYDY CytoDyn Inc
09/18/2020 10:25:51 AM
Actually as we are headed into the
CYDY CytoDyn Inc
09/18/2020 10:04:16 AM
Speaking of NP you said "You can al (1)
CYDY CytoDyn Inc
09/17/2020 10:54:11 AM
I hope you didn't have a coronary w (1)
CYDY CytoDyn Inc
09/17/2020 10:52:11 AM
The weak and even average investors (1)
CYDY CytoDyn Inc
09/17/2020 10:47:55 AM
We have seen NP's true nature and p (6)
CYDY CytoDyn Inc
09/17/2020 10:23:38 AM
You posted "Its not an investment, (4)
CYDY CytoDyn Inc
09/17/2020 8:15:31 AM
You clearly do not understand. I ow (6)
CYDY CytoDyn Inc
09/17/2020 7:54:57 AM
Dr Lalzari has more integrity than (2)
CYDY CytoDyn Inc
09/17/2020 7:45:43 AM
Spot On!! Great drug with unlimited (4)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Cytokinetics Investors: Secure Representation Before Deadline
  • Jasper Therapeutics Investors: Important Class Action Deadline Ahead
  • Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
  • CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
  • Ascletis Completes Enrollment in Phase IIa Study of ASC30.
  • Innovations in Pancreatic Cancer Treatment with Satri-cel
  • Cambodia's Techo International Airport: A Gateway to Growth
  • Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
  • Faraday Future's Vision: Accelerating Towards FX Super One Launch
  • IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
  • Clover Biopharmaceuticals Names Nicholas Jackson as President
  • Dr. Luke Wainscoat Brings Expertise to The Brattle Group
  • Kering and L'Oréal Unite to Transform Luxury Beauty Sector
  • Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
  • Kering Partners with L'Oréal to Transform Luxury Beauty Sector
  • Alice Walton and Elon Musk: Giants of Wealth in 2025
  • Clarins and V Magazine Host a Glamorous Golden Hour Event
  • Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
  • Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
  • Exploring NB HASH and the Transformation of Wealth Today
  • Kevin Hart's Journey From Investment Missteps to Business Success
  • BlackRock's Strategic Shift: The Future of Investment in RWA
  • Major Contract Termination Announced by Vantage Drilling
  • Deadline Approaches for Dow Inc. Investors Amid Legal Action
  • Important Update for Cepton, Inc. Investors on Class Action
  • Target and Walmart Thrive Amid Collectible Card Sales Surge
  • Snap Investors Urged to Consider Leading Legal Action
  • Unlocking Wealth Potential: The RWA Revolution Explained
  • Embracing Real-World Assets with NB HASH for Sustainable Growth
  • Nutex Health Investors Can Join Class Action Against Company
  • Potential Legal Action for Baxter International Investors
  • Solidarity in Aviation: Airline Workers Support Controllers
  • Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
  • Promising Outcomes Unveiled from HARMONi-6 Clinical Study
  • Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
  • Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
  • Promising Findings on Subcutaneous Amivantamab for Cancer
  • Vivace Therapeutics Reports Promising Results for VT3989 Therapy
  • iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
  • Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
  • New Breakthrough Data from Novartis on Prostate Cancer Treatment
  • Transforming Assets: The Role of NB HASH in Digital Wealth
  • The Future of Wealth: Bridging Real-World Assets with Blockchain
  • Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
  • Significant Phase 1a Trial Findings for Faridoxorubicin
  • Major Developments in AI: Insights from Top Tech Executives
  • Celebrating Five Years of Innovations at United Imaging's Hub
  • International Engagement Highlighted at Financial Forum 2025
  • Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
  • Max Stock Limited Reveals Holdings of Key Parties and Officers
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site